SUMO1 antibody
Quick Overview for SUMO1 antibody (ABIN6252735)
Target
See all SUMO1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purification
- Protein G affinity chromatography
-
Immunogen
- Recombinant human protein was used as the immunogen for this SUMO1 antibody.
-
Isotype
- IgG1 kappa
-
-
-
-
Application Notes
-
Flow Cytometry: 0.5-1 μg/million cells
IF: 0.5-1 μg/mL
WB: 0.5-1 μg/mL
IHC (FFPE): 0.5-1 μg/mL for 30 minutes at RT (1)
Prediluted format : incubate for 30 min at RT (2)
Titering of the SUMO1 antibody may be required for optimal performance.1. FFPE testing requires sections to be boiled in pH 6 10 mM citrate buffer for 10-20 minutes, followed by cooling at RT for 20 minutes, prior to staining.
2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- PBS with 0.1 mg/mL BSA and 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot and Store at -20C. Avoid freez-thaw cycles.
-
-
- SUMO1 (Small Ubiquitin Related Modifier Protein 1 (SUMO1))
-
Alternative Name
- SUMO1
-
Background
- The small ubiquitin-related modifier (SUMO) proteins, which include SUMO1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability.
-
Gene ID
- 7341
-
UniProt
- P63165
-
Pathways
- M Phase, Positive Regulation of Endopeptidase Activity, Protein targeting to Nucleus, Ubiquitin Proteasome Pathway
Target
-